Nanomedicine: Principles, Properties, and Regulatory Issues
Autor(a) principal: | |
---|---|
Data de Publicação: | 2018 |
Outros Autores: | , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
Texto Completo: | http://hdl.handle.net/10316/107603 https://doi.org/10.3389/fchem.2018.00360 |
Resumo: | Several scientific areas have benefited significantly from the introduction of nanotechnology and the respective evolution. This is especially noteworthy in the development of new drug substances and products. This review focuses on the introduction of nanomedicines in the pharmaceutical market, and all the controversy associated to basic concepts related to these nanosystems, and the numerous methodologies applied for enhanced knowledge. Due to the properties conferred by the nanoscale, the challenges for nanotechnology implementation, specifically in the pharmaceutical development of new drug products and respective regulatory issues are critically discussed, mainly focused on the European Union context. Finally, issues pertaining to the current applications and future developments are presented. |
id |
RCAP_2d58ecd2ac128b67291df89a597e7029 |
---|---|
oai_identifier_str |
oai:estudogeral.uc.pt:10316/107603 |
network_acronym_str |
RCAP |
network_name_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository_id_str |
7160 |
spelling |
Nanomedicine: Principles, Properties, and Regulatory Issuesnanotechnologynanomedicinenanomaterialspharmaceutical developmentnanotoxicologySeveral scientific areas have benefited significantly from the introduction of nanotechnology and the respective evolution. This is especially noteworthy in the development of new drug substances and products. This review focuses on the introduction of nanomedicines in the pharmaceutical market, and all the controversy associated to basic concepts related to these nanosystems, and the numerous methodologies applied for enhanced knowledge. Due to the properties conferred by the nanoscale, the challenges for nanotechnology implementation, specifically in the pharmaceutical development of new drug products and respective regulatory issues are critically discussed, mainly focused on the European Union context. Finally, issues pertaining to the current applications and future developments are presented.Frontiers Media S.A.2018info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articlehttp://hdl.handle.net/10316/107603http://hdl.handle.net/10316/107603https://doi.org/10.3389/fchem.2018.00360eng2296-2646Soares, SaraSousa, JoãoPais, AlbertoVitorino, Carlainfo:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2023-07-24T08:10:58Zoai:estudogeral.uc.pt:10316/107603Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T21:23:56.276579Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse |
dc.title.none.fl_str_mv |
Nanomedicine: Principles, Properties, and Regulatory Issues |
title |
Nanomedicine: Principles, Properties, and Regulatory Issues |
spellingShingle |
Nanomedicine: Principles, Properties, and Regulatory Issues Soares, Sara nanotechnology nanomedicine nanomaterials pharmaceutical development nanotoxicology |
title_short |
Nanomedicine: Principles, Properties, and Regulatory Issues |
title_full |
Nanomedicine: Principles, Properties, and Regulatory Issues |
title_fullStr |
Nanomedicine: Principles, Properties, and Regulatory Issues |
title_full_unstemmed |
Nanomedicine: Principles, Properties, and Regulatory Issues |
title_sort |
Nanomedicine: Principles, Properties, and Regulatory Issues |
author |
Soares, Sara |
author_facet |
Soares, Sara Sousa, João Pais, Alberto Vitorino, Carla |
author_role |
author |
author2 |
Sousa, João Pais, Alberto Vitorino, Carla |
author2_role |
author author author |
dc.contributor.author.fl_str_mv |
Soares, Sara Sousa, João Pais, Alberto Vitorino, Carla |
dc.subject.por.fl_str_mv |
nanotechnology nanomedicine nanomaterials pharmaceutical development nanotoxicology |
topic |
nanotechnology nanomedicine nanomaterials pharmaceutical development nanotoxicology |
description |
Several scientific areas have benefited significantly from the introduction of nanotechnology and the respective evolution. This is especially noteworthy in the development of new drug substances and products. This review focuses on the introduction of nanomedicines in the pharmaceutical market, and all the controversy associated to basic concepts related to these nanosystems, and the numerous methodologies applied for enhanced knowledge. Due to the properties conferred by the nanoscale, the challenges for nanotechnology implementation, specifically in the pharmaceutical development of new drug products and respective regulatory issues are critically discussed, mainly focused on the European Union context. Finally, issues pertaining to the current applications and future developments are presented. |
publishDate |
2018 |
dc.date.none.fl_str_mv |
2018 |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://hdl.handle.net/10316/107603 http://hdl.handle.net/10316/107603 https://doi.org/10.3389/fchem.2018.00360 |
url |
http://hdl.handle.net/10316/107603 https://doi.org/10.3389/fchem.2018.00360 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
2296-2646 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.publisher.none.fl_str_mv |
Frontiers Media S.A. |
publisher.none.fl_str_mv |
Frontiers Media S.A. |
dc.source.none.fl_str_mv |
reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação instacron:RCAAP |
instname_str |
Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
instacron_str |
RCAAP |
institution |
RCAAP |
reponame_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
collection |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository.name.fl_str_mv |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
repository.mail.fl_str_mv |
|
_version_ |
1799134125220691968 |